Observe Medical signs LOI with German distributor

Oslo, December 8, 2023 - Observe Medical (the "Company" or "Observe Medical") is
excited to announce a significant milestone in our global expansion strategy
with the signing of a Letter of Intent (LOI) for distribution of the UnoMeter
portfolio in the German market.

The agreement marks our entry into the German market and has been formalized
with Siramo, a company led by former key personnel from the previous leading
distributor of UnoMeter products in Germany. Germany has historically been one
of the largest markets for distribution of the UnoMeter product range, which
presents a substantial growth opportunity for our company.

"The signing of a LOI with Siramo marks a significant milestone in our work on
expanding our presence in key markets and building strong relationships with
strategic distribution partners. Being present in the German market, which
historically has been one of the leading markets for the UnoMeter portfolio, is
crucial in our journey of becoming the global leader in the urine measurement
segment. We look forward to the positive impact of this partnership and the
continued growth and success it will bring to Observe Medical." said Observe
Medical CCO, Jørgen Mann.

For further information, please contact:

Rune Nystad, CEO Observe Medical
Mobile: +47 916 24 683
E-mail: rune.nystad@observemedical.com

Per Arne Nygård, CFO Observe Medical
Mobile: +47 411 04 345
E-mail: perarne.nygard@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care,
in combination with targeted M&A.

The Company is headquartered in Oslo, Norway, with additional offices in Narvik,
Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US. In
addition, Observe Medical has a direct sale organization in the Nordics and a
distributor network internationally.

Further information is available at www.observemedical.com.